|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 23, 2017 ) According to Publisher, the Global In Vitro Toxicology Testing Market is accounted for $12.30 billion in 2015 and is expected to reach $32.45 billion by 2022 growing at a CAGR of 14.8% during the forecast period. Factors such as technological advancements and increasing government funding are fueling the market growth. However, strict regulations and predictive ability of in vitro testing over in vivo testing are hampering the market. Growing drug discovery and innovation in the market provides ample of opportunities for players in the market.
For more information http://www.reportsweb.com/in-vitro-toxicology-testing-global-market-outlook-2016-2022
Cellular assay segment dominated the global market with largest share due to wider availability of these techniques for pharmacokinetic profiling along with the presence of significant number of market entities operating in the field of biotechnology. North America dominated the market with more than 35% of the global share owing to encouraging government incentives for laboratory expansion in the region.
Some of the key players in the market include Thermo Fisher Scientific, Covance Inc., Alere Inc., Catalent Pharma Solutions, Inc., Life Technologies, General Electric Company, Sigma-Aldrich Corporation, Agilent Technologies, Inc., Bioreliance, Inc. (A Subsidiary of Merck Kgaa), Quest Diagnostics Incorporated, Charles River Laboratories International, Inc., Accelrys, Eurofins Scientific Se, Bio-Rad Laboratories, Inc. and Cyprotex.
Types Covered:
- Toxic Substance
- Dose
o Threshold Response
o Dose Response
- Absorption, Distribution, Metabolism , and Excretion (ADME)
Technologies Covered:
- Cell Culture Technology
- Molecular Imaging Technologies
- OMICS Technologies
o Metabolomics
o Genomics
o Transcirptomics
o Toxicogenomics
o Proteomics
- High-throughput Technologies
Methods Covered:
- Cellular Assays
- In Silico Method
- Ex Vivo Models
- Biochemical Assays
- Other Methods
End Users Covered:
- Pharmaceutical Industry
- Chemical Industry
- Diagnostics
o Oral Fluid Screening
o Urine Screening
o Hair Screening
o Alcohol Screening
o Other Diagnostics
- Cosmetics & Household Products
- Food Industry
Products Covered:
- Reagents & Labware
- Assays
o Receptor Binding Assays
o Bacterial Toxicity Assays
o Cell-Based ELISA and Western Blots
o Tissue Culture Assays
o Enzyme Toxicity Assays
o Other Assays
Toxicity Endpoints & Tests Covered:
- Ocular Toxicity
- Systemic Toxicity
- Organ Toxicity
- Skin Sensitization & Irritation
- Carcinogenicity
- Neurotoxicity
- Dermal Toxicity
- Genotoxicity
- Other Toxicity Endpoints & Tests
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564970/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
13 Company Profiling
13.1 Thermo Fisher Scientific
13.2 Covance Inc.
13.3 Alere Inc.
13.4 Catalent Pharma Solutions, Inc.
13.5 Life Technologies
13.6 General Electric Company
13.7 Sigma-Aldrich Corporation
13.8 Agilent Technologies, Inc.
13.9 Bioreliance, Inc. (A Subsidiary of Merck Kgaa)
13.10 Quest Diagnostics Incorporated
13.11 Charles River Laboratories International, Inc.
13.12 Accelrys
13.13 Eurofins Scientific Se
13.14 Bio-Rad Laboratories, Inc.
13.15 Cyprotex
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564970/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
